Email: globalbio.me@gmail.com
  970-422-4203

Institutional Acronyms

Washington Obelisk

Institutional Acronyms

  1. AAPAA
    American Academy of Psychiatrists in Alcoholism and Addiction
  2. ABMS
    American Board of Medical Specialties
  3. ABPN
    American Board of Psychiatry and Neurology
  4. ACTH
    adrenocorticotrophic hormone
  5. ADAMHA
    Alcohol, Drug Abuse, and Mental Health Administration
  6. ADD
    Antiepileptic Drug Development Program
  7. ADEPT
    Alcohol and Drug Education for Physician Training
  8. AFDC
    Aid to Families with Dependent Children
  9. AIDS
    acquired immune deficiency syndrome
  10. ALS
    amyotrophic lateral sclerosis (Lou Gehrig’s disease)
  11. AMBHA
    American Managed Behavioral Healthcare Association
  12. AMERSA
    Association for Medical Education and Research in Substance Abuse
  13. AMP
    adenosine 3’5′-monophosphate
  14. ASAM
    American Society of Addiction Medicine
  15. ATC
    addiction training center
  16. AZT
    zidovudine
  17. BDC
    BioDevelopment Corporation
  18. BJS
    Bureau of Justice Statistics
  19. BLS
    Bureau of Labor Statistics
  20. BSMD
    Biobehavioral Sciences and Mental Disorders
  21. CALDATA
    California Drug and Alcohol Treatment Assessment
  22. CASA
    Center on Addiction and Substance Abuse
  23. CBO
    Congressional Budget Office
  24. CDC
    Centers for Disease Control and Prevention
  25. CDDA
    Commission on Medicines for Treatment of Drug Dependence and Abuse
  26. CDER
    Center for Drug Evaluation and Research
  27. CDP
    chemical dependency programs
  28. CME
    continuing medical education
  29. CMHS
    Center for Mental Health Services
  30. CNS
    central nervous system
  31. CPDD
    College on Problems of Drug Dependence
  32. CRADAs
    cooperative research and development agreements
  33. CRS
    Congressional Research Service
  34. CSA
    Controlled Substances Act
  35. CSAP
    Center for Substance Abuse Prevention
  36. CSAT
    Center for Substance Abuse Treatment
  37. CTDP
    Cocaine Treatment Discovery Program
  38. DAWN
    Drug Abuse Warning Network
  39. DD
    drug-discrimination test
  40. DEA
    Drug Enforcement Agency
  41. DHHS
    U.S. Department of Health and Human Services
  42. DPC-PTR
    Drug Price Competition and Patent Term Restoration Act
  43. DSRS
    Drug Services Research Survey
  44. DVA
    Department of Veterans Affairs
  45. FDA
    Food and Drug Administration
  46. FDCA
    Federal Food, Drug, and Cosmetic Act
  47. FTEs
    full-time equivalent personnel
  48. FY
    fiscal year
  49. GAO
    General Accounting Office
  50. HIV
    human immunodeficiency virus
  51. HMO
    health maintenance organization
  52. HRSA
    Health Resources and Services Administration
  53. IDU
    injecting drug-user
  54. IND
    investigational new drug
  55. IOM
    Institute of Medicine
  56. IRB
    institutional review board
  57. K20
    Scientist Development Award for Clinicians
  58. K21
    Scientist Development Award
  59. LAAM
    levo-alpha-acetylmethadol (trade name ORLAAM)
  60. LMA
    locomotor-activity test
  61. LRP
    Loan Repayment Program
  62. MARC
    Minority Access to Research Careers
  63. MDD
    Medications Development Division
  64. MDMA
    Methylenedioxymethamphetamine (“ecstacy”)
  65. MSH
    melanocyte-stimulating hormone
  66. NAS
    National Academy of Sciences
  67. NASADAD
    National Association of State Alcohol and Drug Abuse Directors, Inc.
  68. NATA
    Narcotic Addict Treatment Act
  69. NCDDG-AIDS
    National Cooperative Drug Discovery Groups on Acquired Immune Deficiency Syndrome
  70. NCI
    National Cancer Institute
  71. NCJA
    National Criminal Justice Association
  72. NDA
    new drug application
  73. NDATUS
    National Drug and Alcoholism Treatment Survey
  74. NIAAA
    National Institute on Alcohol Abuse and Alcoholism Administration
  75. NIAID
    National Institute of Allergy and Infectious Diseases
  76. NIDA
    National Institute on Drug Abuse
  77. NIH
    National Institutes of Health
  78. NRC
    National Research Council
  79. NRSA
    National Research Service Awards
  80. ODF
    out-patient drug-free
  81. ONDCP
    Office of National Drug Control Policy
  82. OPRR
    Office of Protection from Research Risks
  83. ORLAAM™
    levo-alpha-acetylmethadol (LAAM)
  84. OTA
    Office of Technology Assessment
  85. PBMs
    pharmaceutical benefit managers
  86. PCP
    phencyclidine
  87. PhRMA
    Pharmaceutical Research and Manufacturers of America
  88. PHS
    Public Health Service
  89. PMA
    Pharmaceutical Manufacturers Association
  90. POMC
    pro-opiomelanocortin
  91. R&D
    research and development
  92. R01
    investigator-initiated grants
  93. R18
    research-demonstration grants
  94. SA
    self-administration test
  95. SADAP
    State Alcohol and Drug Abuse Profile
  96. SAMHSA
    Substance Abuse and Mental Health Services Administration
  97. SSI
    Supplemental Security Income
  98. TB
    tuberculosis
  99. Tcs
    therapeutic communities
  100. TOPS
    Treatment Outcome Prospective Study
  101. TRUs
    treatment research units
  102. VA
    Department of Veterans Affairs
  103. WHO
    World Health Organization